PMID

Data

Article Title

Organization

Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.

Johnson & Johnson Pharmaceutical Research & Development

Structure-activity relationships for substrate-based inhibitors of human complement factor B.

The University of Queensland

Profiling the enzymatic properties and inhibition of human complement factor B.

University of Queensland

Discovery of 4-((2 S,4 S)-4-Ethoxy-1-((5-methoxy-7-methyl-1 H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases

Novartis Institutes For Biomedical Research

Chemical Approaches to Modulating Complement-Mediated Diseases.

The University of Queensland

Quinazoline and indole compounds to treat medical disorders

Achillion Pharmaceuticals

Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof

Novartis

2-benzyl-benzimidazole complement factor B inhibitors and uses thereof

Novartis

Complement factor B inhibitors and uses there of

Novartis

Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof

Novartis